WHO ICTRP trial
Role of Jeevantyadi Avaleha on foetal growth and maternal well-being in second…
CTRI/2021/03/032434 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2021/03/032434 |
|---|---|
| Public title | Role of Jeevantyadi Avaleha on foetal growth and maternal well-being in second trimester of pregnancy |
| Scientific title | ROLE OF JEEVANTYADI AVALEHA IN FOETAL GROWTH AND MATERNAL WELL-BEING DURING SECOND TRIMESTER OF PREGNANCY – A CLINICO-EXPERIMENTAL STUDY |
| Primary sponsor | Institute of Teaching and Research in Ayurveda |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 3 |
| Countries | India |
| Conditions | Health Condition 1: O251- Malnutrition in pregnancy |
| Interventions | Intervention1: a)Jeevantyadi Avaleha b)Calcium Gluconate tablet c)Ferrous Sulphate tablet: (Group A) a) Jeevantyadi Avaleha orally in the dose of 10 gm twice daily before food with milk as anupana (For 16 weeks i.e. from 13th -16th week to… |
| Registration date | Mar 30, 2021 |
| Target size | 100 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: